StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Reported (IFRS) gross profit by Quarter

Reported (IFRS) gross profit ($M) ($M)

QuarterlyAnnual

AstraZeneca Reported (IFRS) gross profit: $12,861M in Q2 2026, up 7.3% from a year earlier. That is the highest of the 27 quarters on record here.

Latest, Q2 2026
12,861
Period ended Jun 30, 2026
Change on a year earlier
+7.3%
11,984 in Q2 2025
History
27 quarters
Since Q2 2017
Sources
26
Documents cited below

Where the Q2 2026 figure comes from

“|| Gross profit | | | 12,861 | | | (8) | | | 8 | | | 2 | | | 12,863 | | 8 | | 6”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Consolidated Income Statement.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported (IFRS) gross profit ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202612,861+7.3%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 202612,610+11.1%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 202512,385+1.8%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 202512,390+18.2%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 202511,984+11.4%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 202511,347+8.5%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 202412,166+25.2%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 202410,484+11.6%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 202410,755+13.7%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 202410,461+16.6%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20239,716+17.0%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20239,397+17.5%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20239,456+21.7%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20238,974+13.9%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20228,307+12.5%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20228,000+31.0%Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Reported (IFRS) gross profit ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep-gross-profit-cmp

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.

See a number that looks wrong?